BASi provides drug discovery and development services and analytical instruments that help pharmaceutical, biotechnology, leading academic institutions and government organizations in their drug development and research efforts. Our mission is to provide drug developers with superior scientific research and innovative analytical instrumentation, which saves time, saves money, and saves lives, to bring revolutionary new drugs to market quickly and safely. Our strategy is to provide services that will generate high-quality and timely data in support of new drug approval or use expansion. To learn more about our portfolio of services and analytical instruments, click here.
Click here to listen to BASi/Inotiv’s presentation at the H.C. Wainwright 22nd Annual Global Investment Conference. Our presentation begins at 2:30 p.m. EDT on September 16.
Chief Financial Officer
BASi Reports First Quarter Results of Fiscal 2020
Friday, February 14, 2020
Annual Shareholders Meeting
March 19, 2020 - 10:30 am
Courtyard Marriott Lafayette
150 Fairington Avenue, Lafayette, IN 47905